EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancement in chiral heterocycles for the antidiabetic activity

Tinku Gupta iD, Dimpy Rani, Lalit Mohan Nainwal, Reena Badhwar

Chirality · 2024-02 · 36 (2)

DOI: 10.1002/chir.23637 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chirality, online erschienen am 21.01.2024. Verfasst von Tinku Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy & Phytochemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Heterocyclic Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Not applicable.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the synthesis and development of pharmaceuticals, chirality is an important structural component. Chiral heterocyclic compounds have annoyed the interest of synthetic chemists who are working to create useful and efficient techniques for these molecules. As indicated by the expanding number of chiral drugs created in the last two decades, the link between chirality and pharmacological activity has become more important in the pharmaceutical and biopharmaceutical industries. Approximately 65% of currently used drugs are chiral, and many of them are promoted as racemates in many circumstances. There are a growing number of new chiral heterocyclic compounds with important biological properties and intriguing uses in medical chemistry and drug discovery. In this study, we review current breakthroughs in chiral heterocycles and their different physiological activities that have been published in the last year (from 2010 to early 2023). This study focuses on the current trends in the use of chiral heterocycles in drug design and the creation of several powerful and competent candidates for diabetic illnesses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsHeterocyclic CompoundsStereoisomerismDrug DesignDrug Discovery

Stichwörter der Autor:innen

biological activitychiralityconfigurationheterocyclicstereo-specificity

Substanzen

Hypoglycemic AgentsHeterocyclic Compounds

Autor:innen und Institutionen

  • Department of Pharmacognosy & Phytochemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India.
  • School of Medical and Allied Sciences, G.D. Goenka University, Haryana, India.
  • Department of Pharmaceutical Chemistry, KIET School of Pharmacy, KIET Group of Institutions, Ghaziabad, India.
  • Department of Pharmacy, SGT University, Budhera, Haryana, India.

ORCID-Profile: Tinku Gupta

Förderung

  • Not applicable

Zitieren

APA

Gupta, T., Rani, D., Nainwal, L. M., & Badhwar, R. (2024). Advancement in chiral heterocycles for the antidiabetic activity. Chirality, 36(2). https://doi.org/10.1002/chir.23637

Vancouver

Gupta T, Rani D, Nainwal LM, Badhwar R. Advancement in chiral heterocycles for the antidiabetic activity. Chirality. 2024;36(2). doi:10.1002/chir.23637

BibTeX
@article{Gupta2024,
  author = {Gupta, Tinku and Rani, Dimpy and Nainwal, Lalit Mohan and Badhwar, Reena},
  title = {Advancement in chiral heterocycles for the antidiabetic activity},
  journal = {Chirality},
  year = {2024},
  volume = {36},
  number = {2},
  doi = {10.1002/chir.23637}
}
Kostenlos starten →